Stericycle (SRCL) Drops Off Stifel Select List
- S&P 500 nears record high on stimulus hopes, strong earnings
- 'Becoming JP Morgan of the Future': Square (SQ) Dips on Deal to Acquire BNPL Afterpay For $29B in Stock, Benefits Outweigh High Price Says Analyst
- Oil prices hit by concern over Chinese economy and higher supply
- ON Semiconductor (ON) Surges on Strong Q2 Results and Q3 Outlook
- Dollar down again as dovish Fed tone prevails ahead of data
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Stifel analyst Michael Hoffman reiterated a Buy rating and $85.00 price target on Stericycle (NASDAQ: SRCL) but removed the name from the Stifel Select List following a 32.6% Y/Y gain.
The analyst stated "Since inclusion on the Select List the stock is up 32.6% compared to the S&P 500 and Russel 2000 up 15.9% and 3.8%, respectively. Our investment thesis remains intact: SRCL is making steady progress executing its five strategic pillars: divest of non-core assets, balance sheet delever, revenue quality, cut excess costs and roll-out a global ERP, the last being delayed by the travel restrictions posed by the pandemic should resume in 1H21."
Shares of Stericycle closed at $67.13 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Levi Strauss & Co. (LEVI) at Buy
- Boeing (BA) Has Work To Do, Turnaround Not Until 2022 - Jefferies
- Teledyne (TDY) PT Raised to $530 at Jefferies as 2021 Results Continue to Strengthen
Create E-mail Alert Related CategoriesAnalyst Comments
Related EntitiesStifel, Standard & Poor's
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!